Dr. Rohit Chandwani, MD

Dr. Chandwani practices at NewYork-Presbyterian/Weill Cornell Medical Center in New York, New York, part of NewYork-Presbyterian Hospital.

Dr. Chandwani's NPI, 1306173521, was assigned on November 9, 2009. Dr. Chandwani graduated from Yale School of Medicine in 2005. Dr. Chandwani holds New York license 244349.

Dr. Chandwani's primary practice is NewYork-Presbyterian/Weill Cornell Medical Center, at 525 East 68th Street, New York, NY 10065 in New York County. The practice phone is (212) 746-5454.

Dr. Chandwani's primary practice is NewYork-Presbyterian/Weill Cornell Medical Center in New York, New York, part of NewYork-Presbyterian Hospital. The medical group on file is Weill Cornell Physicians. Dmand AI also links Dr. Chandwani to 2 more clinical labs and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Chandwani practices, 4 sites in all. Vendor and product names are available with a free account.

Surgical oncology is Dr. Chandwani's primary specialty in the NPI Registry, under taxonomy code 2086X0206X. Dr. Chandwani is board certified in complex general surgical oncology by the American Board of Surgery. Dmand AI has Dr. Chandwani's licenses on file in 2 states: New York and Florida.

CMS data shows 109 Medicare services from Dr. Chandwani across 4 procedure codes in 2024, for 64 Medicare patients. Medicare paid $9,167 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 64 Medicare patients who saw Dr. Chandwani in 2024. The largest group is 65 to 74, with 30 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 20% are also on Medicaid. Their average risk score is 2.34, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Chandwani's median patient age at 71, with 49% women.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 100 out of 100 for Dr. Chandwani for performance year 2024, reported through an alternative payment model (APM). Dr. Chandwani accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Chandwani as offering telehealth.

Dmand AI links 23 papers to Dr. Chandwani, published from 2000 to 2024. 2024 was the busiest year, with 5. The most frequent topics are Pancreatic Neoplasms, Carcinoma, Pancreatic Ductal and Mice, Inbred C57BL. Dr. Chandwani has published most often in Cancer Cell. Dr. Chandwani's most frequent co-authors are William R. Jarnagin, MD, Vinod P. Balachandran, MD and Jeffrey A. Drebin, MD.

CMS Open Payments shows 2 general payments to Dr. Chandwani from 2 drug and device companies in 2018. Food and beverage make up the largest share, 100% of the total. Stimwave Technologies Incorporated paid the most, $88.

Dr. Chandwani graduated from Yale School of Medicine in 2005.

Dr. Chandwani is in network with 15 carriers, including Elevance, Aetna and United Healthcare. PPO plans come from the most carriers, 10. Check the plan with the practice before a visit.